NHC:NYE-National HealthCare Corporation (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 103.2

Change

+0.38 (+0.37)%

Market Cap

USD 1.59B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-2.27 (-0.67%)

USD 89.22B
THC Tenet Healthcare Corporation

-2.28 (-1.66%)

USD 13.48B
UHS Universal Health Services Inc

-1.88 (-0.99%)

USD 12.59B
FMS Fresenius Medical Care Corpora..

-0.11 (-0.56%)

USD 12.44B
DVA DaVita HealthCare Partners Inc

-1.97 (-1.39%)

USD 12.27B
EHC Encompass Health Corp

-0.88 (-1.03%)

USD 8.54B
CHE Chemed Corp

+1.02 (+0.19%)

USD 8.13B
SEM Select Medical Holdings

-0.35 (-1.03%)

USD 4.33B
AGL agilon health Inc

-0.39 (-5.79%)

USD 2.58B
AMN AMN Healthcare Services Inc

+0.60 (+1.14%)

USD 2.01B

ETFs Containing NHC

COAL COAL 4.75 % 0.00 %

+0.20 (+0.84%)

USD 4.10M
RNSC First Trust Small Cap US .. 3.13 % 0.60 %

-0.20 (0.84%)

USD 0.03B
ISPA:F iShares (DE) I - iShares .. 2.11 % 0.00 %

N/A

USD 2.34B
ISPA:XETRA iShares (DE) I - iShares .. 2.11 % 0.00 %

+0.21 (+0.84%)

USD 2.30B
SDGPEX:SW iShares STOXX Global Sele.. 2.10 % 0.00 %

N/A

USD 0.05B
D100:XETRA MULTI-UNITS LUXEMBOURG - .. 2.08 % 0.00 %

+1.08 (+0.84%)

USD 0.04B
CGV Two Roads Shared Trust 1.67 % 0.00 %

-0.07 (0.84%)

USD 0.10B
AFSM First Trust Active Factor.. 0.87 % 0.00 %

-0.15 (0.84%)

USD 0.01B
DESC 0.00 % 0.30 %

N/A

N/A
KOL 0.00 % 0.60 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.66% 48% F 82% B
Dividend Return 0.64% 56% F 25% F
Total Return 12.30% 48% F 80% B-
Trailing 12 Months  
Capital Gain 67.04% 91% A- 96% N/A
Dividend Return 3.82% 89% A- 56% F
Total Return 70.86% 91% A- 97% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.53% 39% F 54% F
Dividend Return 6.67% 52% F 55% F
Total Return 3.14% 100% F 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 26.80% 83% B 40% F
Risk Adjusted Return 24.90% 57% F 47% F
Market Capitalization 1.59B 58% F 61% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.